Independent pharmacies struggle in shifting landscape December 13, 2019 by Kate Cough

https://www.ellsworthamerican.com/uncategorized/independent-pharmacies-struggle-in-shifting-landscape/

Pharmacy Raided After State Revokes Its License: Report No criminal charges have been filed against the pharmacy's owners, although it has been ordered to pay a $50,000 fine, according to reports. By Mark Hand, Patch Staff Dec 13, 2019 7:56 am ET | Updated Dec 13, 2019 11:28 pm ET

https://patch.com/virginia/leesburg/leesburg-pharmacy-raided-after-state-revokes-its-license-report

DEA, state and local authorities shut down Lansdowne Pharmacy after raid By John Battiston, jbattiston@loudountimes.com Dec 12, 2019 Updated Dec 13, 2019

https://www.loudountimes.com/news/dea-state-and-local-authorities-shut-down-lansdowne-pharmacy-after/article_d8072c6a-1cfe-11ea-a5b1-13ba89db81d3.html

Woman sues CVS, alleges she was denied 'morning after' pill

https://6abc.com/society/woman-sues-cvs-alleges-she-was-denied-morning-after-pill/5754991/

American Pharmacists Association: Home

www.pharmacist.com

14 hours ago - Chuck Grassley (R-IA) and Ron Wyden (D-OR) have released a new drug pricing bill that includes language that would require price concessions to be inclu

Federal Register/Vol. 84, No. 241/Monday ... - GovInfo

https://www.govinfo.gov › content › pkg › pdf

13 hours ago - on ''Qualification Process for Drug. Development Tools.'' It does not ... guidances-drugs, https://www.fda.gov/ .... Although compounded drugs can serve an.

Agency Information Collection Activities ... - Federal Register

https://www.federalregister.gov › documents › 2019/12/16 › agency-infor...

12 hours ago - Drug compounding is generally the practice of combining, mixing, or altering ingredients of a drug to create a medication tailored to the needs of an individual patient.

FDA issues warning letter for not including the most serious risks in advertisement for medication-assisted treatment drug

The U.S. Food and Drug Administration today posted a warning letter to Alkermes, Inc. of Massachusetts, for misbranding the drug Vivitrol (an extended-release injection formulation of naltrexone) by omitting warnings about the most serious risks associated with the drug from promotional materials. Vivitrol is approved for the prevention of relapse to opioid dependence, following opioid detoxification and should be part of a comprehensive management program that includes psychosocial support. Known as medication-assisted treatment, the use of medications like Vivitrol, in combination with counseling and behavioral therapies, is effective in the treatment of opioid use disorder (OUD) and can help some people to sustain recovery. The warning letter was issued in relation to a print advertisement about Vivitrol. While the print advertisement contains claims and representations about the drug’s benefits, it fails to ...

Read More

12/10/2019	11/26/2019	Vapes by Enushi	Center for Tobacco Products	Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
12/10/2019	11/26/2019	Ralfy's Emporium	Center for Tobacco Products	Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
12/10/2019	11/26/2019	Vape 180 LLC	Center for Tobacco Products	Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded

12/10/2019	11/26/2019	VitaCig Canada	Center for Tobacco Products	Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
12/10/2019	11/26/2019	TJ's E-Cigarettes Limited	Center for Tobacco Products	Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded

12/10/2019

11/18/2019

Valley Proteins, Inc.

Division of Human and Animal Food Operations East II (HAFE2)

New Animal Drug/Adulterated